{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:41:34Z","timestamp":1791189694505,"version":"4.1.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.pain.2012.01.015","type":"journal-article","created":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T21:04:40Z","timestamp":1329771880000},"page":"869-875","source":"Crossref","is-referenced-by-count":40,"title":["Is treatment of postherpetic neuralgia in the community consistent with evidence-based recommendations?"],"prefix":"10.1097","volume":"153","author":[{"given":"Robert H.","family":"Dworkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Panarites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward P.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sissi V.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R5-22-20210126","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2009 revision.","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol"},{"key":"R10-22-20210126","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain.","volume":"13","author":"Attal","year":"2006","journal-title":"Eur J Neurol"},{"key":"R15-22-20210126","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S1474-4422(08)70228-X","article-title":"NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.","volume":"7","author":"Backonja","year":"2008","journal-title":"Lancet Neurol"},{"key":"R20-22-20210126","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00002508-198809000-00007","article-title":"Shingles and postherpetic neuralgia.","volume":"4","author":"Bhala","year":"1988","journal-title":"Clin J Pain"},{"key":"R25-22-20210126","first-page":"244","article-title":"Acute herpes zoster and postherpetic neuralgia: effects of acyclovir and outcome of treatment with amitriptyline.","volume":"42","author":"Bowsher","year":"1992","journal-title":"Br J Gen Pract"},{"key":"R30-22-20210126","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0885-3924(97)00077-8","article-title":"The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial.","volume":"13","author":"Bowsher","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"R35-22-20210126","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R40-22-20210126","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.","volume":"10","author":"Chou","year":"2009","journal-title":"J Pain"},{"key":"R45-22-20210126","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jpain.2004.06.001","article-title":"Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the Brief Pain Inventory.","volume":"5","author":"Coplan","year":"2004","journal-title":"J Pain"},{"key":"R50-22-20210126","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1468-1331.2007.01916.x","article-title":"EFNS guidelines on neurostimulation therapy for neuropathic pain.","volume":"14","author":"Cruccu","year":"2007","journal-title":"Eur J Neurol"},{"key":"R55-22-20210126","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.pain.2008.03.002","article-title":"Incidence rates and treatment of neuropathic pain conditions in the general population.","volume":"137","author":"Dieleman","year":"2008","journal-title":"Pain"},{"key":"R60-22-20210126","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/01.WNL.0000140708.62856.72","article-title":"Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology.","volume":"63","author":"Dubinsky","year":"2004","journal-title":"Neurology"},{"key":"R65-22-20210126","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archneur.60.11.1524","article-title":"Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.","volume":"60","author":"Dworkin","year":"2003","journal-title":"Arch Neurol"},{"key":"R70-22-20210126","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.jpain.2007.10.008","article-title":"Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia.","volume":"9","author":"Dworkin","year":"2008","journal-title":"J Pain"},{"key":"R75-22-20210126","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster.","volume":"44","author":"Dworkin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R80-22-20210126","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpain.2009.08.005","article-title":"Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs.","volume":"11","author":"Dworkin","year":"2010","journal-title":"J Pain"},{"key":"R85-22-20210126","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","article-title":"Recommendations for the pharmacologic management of neuropathic pain: an overview and literature update.","volume":"85","author":"Dworkin","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"R90-22-20210126","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations.","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"R95-22-20210126","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1532-5415.2011.03403.x","article-title":"Healthcare utilization in patients with postherpetic neuralgia and painful diabetic peripheral neuropathy.","volume":"59","author":"Dworkin","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"R100-22-20210126","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1532-5415.2007.01231.x","article-title":"Health care costs of acute and chronic pain associated with a diagnosis of herpes zoster.","volume":"55","author":"Dworkin","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"R105-22-20210126","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1526-4637.2006.00196.x","article-title":"Health care expenditure burden of persisting herpes zoster pain.","volume":"9","author":"Dworkin","year":"2008","journal-title":"Pain Med"},{"key":"R110-22-20210126","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pain.2010.06.019","article-title":"The evidence for pharmacological treatment of neuropathic pain.","volume":"150","author":"Finnerup","year":"2010","journal-title":"Pain"},{"key":"R115-22-20210126","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ejpain.2006.10.004","article-title":"Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings.","volume":"11","author":"Gore","year":"2007","journal-title":"Eur J Pain"},{"key":"R120-22-20210126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2296-9-26","article-title":"Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005.","volume":"9","author":"Hall","year":"2008","journal-title":"BMC Family Pract"},{"key":"R125-22-20210126","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pain.2006.01.030","article-title":"Epidemiology and treatment of neuropathic pain: the UK primary care perspective.","volume":"122","author":"Hall","year":"2006","journal-title":"Pain"},{"key":"R130-22-20210126","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1371\/journal.pmed.0020164","article-title":"Analgesic therapy in postherpetic neuralgia: a quantitative systematic review.","volume":"2","author":"Hempenstall","year":"2005","journal-title":"PLoS Med"},{"key":"R135-22-20210126","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1526-4637.2010.01004.x","article-title":"A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.","volume":"12","author":"Irving","year":"2011","journal-title":"Pain Med"},{"key":"R140-22-20210126","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1212\/01.wnl.0000259085.61898.9e","article-title":"The impact of neuropathic pain on health-related quality of life: review and implications.","volume":"68","author":"Jensen","year":"2007","journal-title":"Neurology"},{"key":"R145-22-20210126","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pain.2010.09.023","article-title":"Complementary and alternative medicine in chronic pain.","volume":"152","author":"Lee","year":"2011","journal-title":"Pain"},{"key":"R150-22-20210126","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejpain.2005.01.014","article-title":"The burden of neuropathic pain: results from a cross-sectional survey.","volume":"10","author":"McDermott","year":"2006","journal-title":"Eur J Pain"},{"key":"R155-22-20210126","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1056\/NEJMsa022615","article-title":"The quality of health care delivered to adults in the United States.","volume":"348","author":"McGlynn","year":"2003","journal-title":"N Engl J Med"},{"key":"R160-22-20210126","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2007\/730785","article-title":"Pharmacological management of chronic neuropathic pain: consensus statement and guidelines from the Canadian Pain Society.","volume":"12","author":"Moulin","year":"2007","journal-title":"Pain Res Manage"},{"key":"R165-22-20210126","first-page":"1","article-title":"Neuropathic pain: a review of the quality-of-life impact, costs, and cost effectiveness of therapy.","volume":"27","author":"OConnor","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"R170-22-20210126","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jpain.2005.01.359","article-title":"Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey.","volume":"6","author":"Oster","year":"2005","journal-title":"J Pain"},{"key":"R175-22-20210126","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/522162","article-title":"The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.","volume":"197","author":"Reynolds","year":"2008","journal-title":"J Infect Dis"},{"key":"R180-22-20210126","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/651078","article-title":"Increasing incidence of herpes zoster among veterans.","volume":"50","author":"Rimland","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R185-22-20210126","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1017\/S0950268807007893","article-title":"Secular trends in the epidemiology of shingles in Alberta.","volume":"135","author":"Russell","year":"2007","journal-title":"Epidemiol Infect"},{"key":"R190-22-20210126","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.clinthera.2011.09.026","article-title":"Relationship between patient-reported chronic low back pain severity and medication resources.","volume":"33","author":"Taylor-Stokes","year":"2011","journal-title":"Clin Ther"},{"key":"R195-22-20210126","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.4065\/mcp.2009.0648","article-title":"Assessment and treatment of psychosocial comorbidities in patients with neuropathic pain.","volume":"85","author":"Turk","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"R200-22-20210126","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/ageing\/afj048","article-title":"A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia.","volume":"35","author":"Van Seventer","year":"2006","journal-title":"Age Ageing"},{"key":"R205-22-20210126","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pain.2009.03.013","article-title":"Non-steroidal anti-inflammatory drugs and neuropathic pain: how do we explain continued widespread use?","volume":"143","author":"Vo","year":"2009","journal-title":"Pain"},{"key":"R210-22-20210126","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4065\/84.9.787","article-title":"Health care utilization and cost burden of herpes zoster in a community population.","volume":"84","author":"Yawn","year":"2009","journal-title":"Mayo Clin Proc"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006396-201204000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:37:52Z","timestamp":1786048672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006396-201204000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2012.01.015","relation":{},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}